Cargando…
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
INTRODUCTION: Pulmonary arterial hypertension (PAH) is a major cause of mortality in systemic sclerosis (SSc). Screening guidelines for PAH recommend multiple investigations, including annual echocardiography, which together have low specificity and may not be cost-effective. We sought to evaluate t...
Autores principales: | Thakkar, Vivek, Stevens, Wendy, Prior, David, Youssef, Peter, Liew, Danny, Gabbay, Eli, Roddy, Janet, Walker, Jennifer G, Zochling, Jane, Sahhar, Joanne, Nash, Peter, Lester, Susan, Rischmueller, Maureen, Proudman, Susanna M, Nikpour, Mandana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978999/ https://www.ncbi.nlm.nih.gov/pubmed/24246100 http://dx.doi.org/10.1186/ar4383 |
Ejemplares similares
-
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
por: Hao, Yanjie, et al.
Publicado: (2015) -
N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
por: Thakkar, Vivek, et al.
Publicado: (2012) -
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012) -
The association of low complement with disease activity in systemic sclerosis: a prospective cohort study
por: Esposito, James, et al.
Publicado: (2016) -
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
por: Morrisroe, Kathleen, et al.
Publicado: (2017)